{
  "case_id": "pfizer-rd-cost-avoidance-ai-modeling",
  "sources": [
    {
      "source_id": "S1",
      "title": "Pioneering the Future of Healthcare: Pfizer's AI Advantage",
      "url": "https://insights.pfizer.com/pfizer's-ai-advantage",
      "doc_type": "Blog Post"
    },
    {
      "source_id": "S2",
      "title": "Pfizer's Digital Transformation Journey: From COVID Response to Full-Scale Generative AI",
      "url": "https://dhitglobal.org/pfizers-digital-transformation-journey-from-covid-response-to-full-scale-generative-ai/",
      "doc_type": "Case Study"
    },
    {
      "source_id": "S3",
      "title": "Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp",
      "url": "https://www.biospace.com/business/pfizer-announces-another-1-7b-in-cost-savings-including-r-d-revamp",
      "doc_type": "News Article"
    },
    {
      "source_id": "S4",
      "title": "How Pfizer Cut Drug Discovery Time From Years to 30 Days (And What Every CEO Can Learn)",
      "url": "https://chiefaiofficer.com/blog/how-pfizer-cut-drug-discovery-time-from-years-to-30-days-and-what-every-ceo-can-learn/",
      "doc_type": "Case Study"
    }
  ]
}